| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |